Post-treatment ECG/Holter findings with statistical significance according to age of children with oral Chagas disease, Chacao, Caracas, Venezuela, 2008–2017 (Abnormalities without statistical significance were not shown).

Post-treatment ECG/Holter findings with statistical significance according to age of children with oral Chagas disease, Chacao, Caracas, Venezuela, 2008–2017 (Abnormalities without statistical significance were not shown).</p

Incidence of clinical findings in the follow-up of 106 patients with oral Chagas disease, Chacao. Caracas.

Incidence of clinical findings in the follow-up of 106 patients with oral Chagas disease, Chacao. Caracas.</p

S4 Data -

Incidence of clinical (A) and ECG/Holter (B) findings after treatment in 106 patients with Chagas disease orally acquired, Chacao, Caracas, Venezuela, 2008–2017. (TIF)</p

Absolute number of evaluated patients with oral Chagas disease according to age group before and after the first treatment, Chacao, Caracas, Venezuela 2007–2017.

Absolute number of evaluated patients with oral Chagas disease according to age group before and after the first treatment, Chacao, Caracas, Venezuela 2007–2017.</p

Fig 4 -

Definitive persistence or disappearance of clinical (A) or ECG/Holter (B) findings after the first treatment 2008–2017, in patients with Chagas disease acquired by the oral route, Chacao, Caracas, Venezuela (p value according to the McNemar χ2 test comparing persistence versus disappearance).</p

Prevalence of significant associations between the pre and post-treatment clinical and ECG/Holter findings in 106 patients with acute Chagas disease acquired by the oral route, Chacao, Caracas, Venezuela, 2007–2017.

Prevalence of significant associations between the pre and post-treatment clinical and ECG/Holter findings in 106 patients with acute Chagas disease acquired by the oral route, Chacao, Caracas, Venezuela, 2007–2017.</p

Cumulative incidence of clinical and ECG/Holter findings after treatment in 106 patients with Chagas disease orally acquired, Chacao, Caracas, Venezuela, 2008–2017.

Cumulative incidence of clinical and ECG/Holter findings after treatment in 106 patients with Chagas disease orally acquired, Chacao, Caracas, Venezuela, 2008–2017.</p

S5 Data -

Definitive persistence or disappearance of clinical (A) or ECG/Holter (B) after the first treatment, 2008–2017, in patients with Chagas disease acquired by the oral route, Chacao, Caracas, Venezuela. (DOCX)</p

Incidence of ECG/Holter abnormalities in 106 patients with Chagas disease orally acquired, Chacao, Caracas, Venezuela, 2007–2017.

Incidence of ECG/Holter abnormalities in 106 patients with Chagas disease orally acquired, Chacao, Caracas, Venezuela, 2007–2017.</p

Descriptive flowchart of the complete follow-up of patients with Chagas disease acquired by the oral route, Chacao, Caracas, Venezuela, 2007–2017.

Descriptive flowchart of the complete follow-up of patients with Chagas disease acquired by the oral route, Chacao, Caracas, Venezuela, 2007–2017.</p